$IBIO
iBio, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$1.27
▲+1.78%+$0.022
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateiBio, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is IBIO up today? It is at $1.27 (+1.78%), and our scanner flagged it 17 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IBIO spikes, and full due diligence on IBIO — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $IBIO 17 times in the last 30 days. Create a free account to track $IBIO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on IBIO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IBIO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Banjak Marc Officer | Bought (open market) | +14K 0.02% of company | added 100% | 25K | $23K at $1.64 | Mar 26, 26 |
Brenner Martin Officer | Bought (open market) | +12K 0.02% of company | added 67% | 31K | $25K at $2.02 | Mar 19, 26 |
Duran Felipe Officer | Bought (open market) | +25K 0.04% of company | added 100% | 36K | $50K at $2.02 | Mar 19, 26 |
Sender Gary Director | Bought (open market) | +9K 0.01% of company | n/a | 9K | $25K at $2.72 | Jan 10, 25 |
Parada Antonio Bernardino Guimaraes Director | Bought (open market) | +184K 0.3% of company | n/a | 184K | $500K at $2.72 | Jan 10, 25 |
Clark William D Director | Bought (open market) | +2K | n/a | 2K | $5K at $2.72 | Jan 10, 25 |
Arkowitz David Director | Bought (open market) | +18K 0.03% of company | n/a | 18K | $50K at $2.72 | Jan 10, 25 |
Banjak Marc Officer | Bought (open market) | +9K 0.01% of company | added 100% | 11K | $25K at $2.72 | Jan 10, 25 |
Brenner Martin Officer | Bought (open market) | +9K 0.01% of company | added 100% | 18K | $25K at $2.72 | Jan 10, 25 |
Duran Felipe Officer | Bought (open market) | +9K 0.01% of company | added 100% | 11K | $25K at $2.72 | Jan 10, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on IBIO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IBIO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
IBIO last traded at $1.27, up 1.78% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
iBio, Inc. Common Stock (IBIO) is next expected to report earnings on Wednesday, November 11, 2026, about 52 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The IBIO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IBIO 17 times in the last 30 days.
IBIO (iBio, Inc. Common Stock) trades on XNAS, with a market cap of about $82M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IBIO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$IBIO discussion
Sign in to ask a question or join the discussion.